Glucocorticoid Receptor β (GRβ) : Beyond Its Dominant-Negative Function

Glucocorticoids (GCs) act via the GC receptor (GR), a receptor ubiquitously expressed in the body where it drives a broad spectrum of responses within distinct cell types and tissues, which vary in strength and specificity. The variability of GR-mediated cell responses is further extended by the existence of GR isoforms, such as GRα and GRβ, generated through alternative splicing mechanisms. While GRα is the classic receptor responsible for GC actions, GRβ has been implicated in the impairment of GRα-mediated activities. Interestingly, in contrast to the popular belief that GRβ actions are restricted to its dominant-negative effects on GRα-mediated responses, GRβ has been shown to have intrinsic activities and "directly" regulates a plethora of genes related to inflammatory process, cell communication, migration, and malignancy, each in a GRα-independent manner. Furthermore, GRβ has been associated with increased cell migration, growth, and reduced sensitivity to GC-induced apoptosis. We will summarize the current knowledge of GRβ-mediated responses, with a focus on the GRα-independent/intrinsic effects of GRβ and the associated non-canonical signaling pathways. Where appropriate, potential links to airway inflammatory diseases will be highlighted.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:22

Enthalten in:

International journal of molecular sciences - 22(2021), 7 vom: 31. März

Sprache:

Englisch

Beteiligte Personen:

Ramos-Ramírez, Patricia [VerfasserIn]
Tliba, Omar [VerfasserIn]

Links:

Volltext

Themen:

7S5I7G3JQL
Apoptosis
Dexamethasone
GRβ
GR isoforms
Glucocorticoid receptor alpha
Glucocorticoid receptor beta
Glucocorticoids
Inflammation
Journal Article
Metabolism
Migration
Proliferation
Protein Isoforms
Receptors, Glucocorticoid
Review

Anmerkungen:

Date Completed 10.05.2021

Date Revised 10.05.2021

published: Electronic

Citation Status MEDLINE

doi:

10.3390/ijms22073649

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM323629695